COA/TZ-2026-067Verified
Save as PDFCertificate of Analysis
PuriLab Analytical
Tirzepatide 30 mg
TZ-2026-067Lot 20-10-02Analyzed November 14, 2026
Timeline
Ordered
October 25, 2026
Received
November 13, 2026
Analyzed
November 14, 2026
Sample
Name
Tirzepatide 30 mg
Expected
Tirzepatide
Amount
1 vial, lyophilized powder
Testing
Client
SALT Peptides
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
30.50mg
Label claim: 30 mg
Purity, how clean it is
99.9%
Measured, not estimated. Purity is calculated from the full chromatogram shown above, and no impurity peaks were detected above the reporting threshold.
Chromatogram
HPLC-UV
19.01 min, Tirzepatide, 99.9%
Analyst Comments
White lyophilized powder, green-cap vial, received sealed.
Analyst Signature
Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 14, 2026
Verification Code
TZ-31B2-QGF9
Verify at purilab.org/verify/TZ-31B2-QGF9
Scan to Verify
TZ-31B2-QGF9
Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.
PuriLab Analytical|admin@purilab.org
Page 1 of 1